• 5077 Citations
  • 39 h-Index
1989 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Annette Kopp-Schneider is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Neoplasms Medicine & Life Sciences
Carcinogenesis Medicine & Life Sciences
Hepatocytes Medicine & Life Sciences
Multistage Model Mathematics
Toxicity Chemical Compounds
Tumors Chemical Compounds
Liver Medicine & Life Sciences
Neuroblastoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

1 Citation (Scopus)

18 F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab

Sachpekidis, C., Kopp-Schneider, A., Hakim-Meibodi, L., Dimitrakopoulou-Strauss, A. & Hassel, J. C., Apr 1 2019, In : Melanoma research. 29, 2, p. 178-186 9 p.

Research output: Contribution to journalArticle

Longitudinal Studies
Disease-Free Survival
1 Citation (Scopus)

Associations of diet and lifestyle factors with common volatile organic compounds in exhaled breath of average-risk individuals

Krilaviciute, A., Leja, M., Kopp-Schneider, A., Barash, O., Khatib, S., Amal, H., Broza, Y. Y., Polaka, I., Parshutin, S., Rudule, A., Haick, H. & Brenner, H., Mar 1 2019, In : Journal of Breath Research. 13, 2, 026006.

Research output: Contribution to journalArticle

Volatile Organic Compounds
Life Style

A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice

Das, K., Eisel, D., Vormehr, M., Müller-Decker, K., Hommertgen, A., Jäger, D., Zörnig, I., Feuerer, M., Kopp-Schneider, A., Osen, W. & Eichmüller, S. B., Sep 13 2019, In : BMC cancer. 19, 1, 1 p.

Research output: Contribution to journalArticle

Open Access
Transgenic Mice
Breast Neoplasms
2 Citations (Scopus)

Can benign lymphoid tissue changes in 18 F-FDG PET/CT predict response to immunotherapy in metastatic melanoma?

Sachpekidis, C., Larribère, L., Kopp-Schneider, A., Hassel, J. C. & Dimitrakopoulou-Strauss, A., Feb 13 2019, In : Cancer Immunology, Immunotherapy. 68, 2, p. 297-303 7 p.

Research output: Contribution to journalArticle

Lymphoid Tissue
Lymph Nodes

Corrigendum: Investigation of Nrf2, AhR and ATF4 activation in toxicogenomic databases (Frontiers Media S.A. (2018) 9 (429) DOI: 10.3389/fgene.2018.00429)

Zgheib, E., Limonciel, A., Jiang, X., Wilmes, A., Wink, S., Van De Water, B., Kopp-Schneider, A., Bois, F. Y. & Jennings, P., Jan 1 2019, In : Frontiers in Genetics. 10, JUN, 517.

Research output: Contribution to journalComment/debate

Open Access
Gift Giving
Organized Financing
European Union